High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial
Article
Illerhaus, Gerald, Kasenda, Benjamin, Ihorst, Gabriele, Egerer, Gerlinde, Lamprecht, Monika, Keller, Ulrich, Wolf, Hans-Heinrich, Hirt, Carsten, Stilgenbauer, Stephan, Binder, Mascha, Hau, Peter, Edinger, Matthias
, Frickhofen, Norbert, Bentz, Martin, Möhle, Robert, Röth, Alexander, Pfreundschuh, Michael, von Baumgarten, Louisa, Deckert, Martina, Hader, Claudia, Fricker, Heidi, Valk, Elke, Schorb, Elisabeth, Fritsch, Kristina and Finke, Jürgen
(2016)
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.
The Lancet Haematology 3 (8), e388-e397.
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | The Lancet Haematology | ||||
| Publisher | Elsevier | ||||
| Place of Publication | OXFORD | ||||
| Volume | 3 | ||||
| Number of Issue or Book Chapter | 8 | ||||
| Page Range | e388-e397 | ||||
| Date | 2016 | ||||
| Date of publication | 17 Mar 2020 11:33 | ||||
| Institutions | Medicine > Lehrstuhl für Neurologie | ||||
| Identification Number |
| ||||
| Keywords | CENTRAL-NERVOUS-SYSTEM; WHOLE-BRAIN RADIOTHERAPY; NON-HODGKIN-LYMPHOMA; 1ST-LINE TREATMENT; CENTER EXPERIENCE; RADIATION-THERAPY; RESPONSE CRITERIA; CLINICAL-TRIALS; PLUS RITUXIMAB; FOLLOW-UP; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 42532 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric